0000876661-18-001231.txt : 20181116
0000876661-18-001231.hdr.sgml : 20181116
20181116145505
ACCESSION NUMBER: 0000876661-18-001231
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20181116
DATE AS OF CHANGE: 20181116
EFFECTIVENESS DATE: 20181116
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: ASTRAZENECA PLC
CENTRAL INDEX KEY: 0000901832
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11960
FILM NUMBER: 181189581
BUSINESS ADDRESS:
STREET 1: 1 FRANCIS CRICK AVENUE
STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB2 0AA
BUSINESS PHONE: 011 44 20 7304 5000
MAIL ADDRESS:
STREET 1: 1 FRANCIS CRICK AVENUE
STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB2 0AA
FORMER COMPANY:
FORMER CONFORMED NAME: ZENECA GROUP PLC
DATE OF NAME CHANGE: 19930422
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NEW YORK STOCK EXCHANGE LLC
CENTRAL INDEX KEY: 0000876661
IRS NUMBER: 000000000
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-2060
MAIL ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK STOCK EXCHANGE INC
DATE OF NAME CHANGE: 19910628
25-NSE
1
primary_doc.xml
X0203
0000876661
NEW YORK STOCK EXCHANGE LLC
901832
ASTRAZENECA PLC
001-11960
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge
CB2 0AA
+44 20 3749 5000
Floating Rate Notes due 2018
17 CFR 240.12d2-2(a)(2)
Victoria Paper
Senior Analyst
2018-11-16
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on November 27, 2018, pursuant to the provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(2) That the entire class of this security was redeemed or paid at maturity or retirement on November 16, 2018.
The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading on November 16, 2018.